Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of dry eye syndrome

• 收藏
• 分享

专利权人:

Xigen Inflammation Ltd.

发明人:

Combette, Jean-Marc,Deloche, Catherine

申请号：

AU2012344299

公开号：

AU2012344299A1

申请日:

2012.11.30

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of dry eye syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/